CO2020005768A2 - Composición fitoconcentrada y sus usos - Google Patents
Composición fitoconcentrada y sus usosInfo
- Publication number
- CO2020005768A2 CO2020005768A2 CONC2020/0005768A CO2020005768A CO2020005768A2 CO 2020005768 A2 CO2020005768 A2 CO 2020005768A2 CO 2020005768 A CO2020005768 A CO 2020005768A CO 2020005768 A2 CO2020005768 A2 CO 2020005768A2
- Authority
- CO
- Colombia
- Prior art keywords
- composition
- phytoconcentrated
- sedative
- antidepressant
- calming
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Neurosurgery (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Biochemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Confectionery (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1759583 | 2017-10-12 | ||
| PCT/FR2018/000233 WO2019073127A2 (fr) | 2017-10-12 | 2018-10-08 | Composition phytoconcentrée et ses utilisations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO2020005768A2 true CO2020005768A2 (es) | 2020-07-31 |
Family
ID=65818034
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CONC2020/0005768A CO2020005768A2 (es) | 2017-10-12 | 2020-05-12 | Composición fitoconcentrada y sus usos |
Country Status (2)
| Country | Link |
|---|---|
| CO (1) | CO2020005768A2 (fr) |
| WO (1) | WO2019073127A2 (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114929033A (zh) * | 2019-07-29 | 2022-08-19 | 布莱特西德公司 | 改善消化健康的方法 |
| EP4098254A1 (fr) * | 2021-06-04 | 2022-12-07 | Assistance Publique, Hopitaux De Paris | Cannabidiol à utiliser dans le traitement de la douleur résultant d'une maladie liée à l'indoléamine 2,3-dioxygenase-1 (ido1) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH695661A5 (de) * | 2001-03-06 | 2006-07-31 | Forsch Hiscia Ver Fuer Krebsfo | Pharmazeutische Zusammensetzung. |
| FR2973706B1 (fr) | 2011-04-06 | 2016-05-20 | Guyen Gerard Duc N | Composition phyto-concentree essentielle decontracturante antispasmodique et de confort musculaire |
| CN103082275A (zh) * | 2011-10-28 | 2013-05-08 | 冯松平 | 一种女性专用饮料泡腾片 |
| US9763991B2 (en) | 2013-06-13 | 2017-09-19 | Cannabis Science International Holding B.V. | Composition for the treatment of neurobehavioral disorders |
-
2018
- 2018-10-08 WO PCT/FR2018/000233 patent/WO2019073127A2/fr active Application Filing
-
2020
- 2020-05-12 CO CONC2020/0005768A patent/CO2020005768A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2019073127A2 (fr) | 2019-04-18 |
| WO2019073127A3 (fr) | 2019-08-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SV2017005426A (es) | Derivados de feniltriazol sustituido con hidroxialquilo y sus usos | |
| SV2018005771A (es) | Derivados de piridiniltriazol sustituidos con amida y usos de estos | |
| BR112018076601A2 (pt) | formulação farmacêutica oral, métodos para tratar um paciente, e, uso de uma formulação | |
| GT200900096A (es) | Formas de dosificación de clorhidrato de palonosetron que tienen estabilidad y biodisponibilidad mejorada | |
| MA45562A (fr) | Préparation pharmaceutique liquide stable | |
| MA46334A (fr) | Composition pharmaceutique liquide | |
| CO2020005768A2 (es) | Composición fitoconcentrada y sus usos | |
| UY37221A (es) | Derivados de feniltriazol sustituidos con amida y usos de estos | |
| IL253237A0 (en) | Use of pill / tablet / capsule minocycline acyclogonosine, atorvastatin and vitamin D in the treatment of rheumatoid arthritis | |
| CL2018003502A1 (es) | Métodos para tratar la osificación heterotópica. | |
| MX2018000546A (es) | Composiciones farmaceuticas que contienen celecoxib y tramadol. | |
| ES2969014T3 (es) | Comprimidos de liberación inmediata que contienen un fármaco y procesos para la formación de los comprimidos | |
| GT201700007A (es) | Formulación en forma de tableta de 2-fluor-n-metil-4-[7-(quinolin-6-ylmetil)imidazo[1,2-b] [1,2,4]triazin-2-il]benzamida | |
| CL2019000563S1 (es) | Envase y dispendio de medicamentos. (divisional solicitud 201800718) | |
| SI3102187T1 (sl) | Stabilne farmacevtske sestave, ki vsebujejo sitagliptin v obliki tablet s takojšnjim sproščanjem | |
| CO2018002428A2 (es) | Amida seleccionada de ácido gamma-hidroxiburico y usos de la misma en el tratamiento de abuso de alcohol | |
| UY31662A1 (es) | Composiciones de tabletas de ranitidina de desintegracion oral y sus metodos de elaboracion. | |
| CR20190022A (es) | Combinación de un inhibidor de blc-2 y un inhibidor de mcl1, usos y composiciones farmacéuticas de estos | |
| CO2017006985A2 (es) | Producto de administración oral | |
| CR20170125A (es) | Composición farmacéutica sólica que comprende amlodipina y losartán | |
| IL263976B1 (en) | Preparations containing memantin and melatonin | |
| CL2018002765A1 (es) | Proceso de producción de formulaciones sólidas de mesalazina. | |
| CL2017000026A1 (es) | Formas de dosificación farmacéutica | |
| PT3246058T (pt) | Dispositivo para a preparação e administração de substâncias líquidas, em particular, fármacos para quimioterapia antiblástica | |
| MX2020004546A (es) | Composiciones farmaceuticas orales de lorazepam resistentes al alcohol. |